Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ovid Therapeutics Inc (NQ: OVID )

2.500 +0.020 (+0.81%)
Streaming Delayed Price Updated: 10:30 AM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ovid Therapeutics Inc

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum
From Ovid Therapeutics Inc.
Via Globe NewsWire
Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial
A Potential, Next-Generation GABA-Aminotransferase Inhibitor for Rare Epilepsies with Limited Treatment Options 
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)
From Ovid Therapeutics Inc.
Via Globe NewsWire
Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
From Ovid Therapeutics Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.